Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|February 27, 2019
Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular HealthMatthew F Wipperman, David C Montrose, Antonio M Gotto, et al.
European Journal of Pharmacology|April 21, 2009
Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cellsBrian D Lamon, Barbara D Summers, Antonio M Gotto, et al.
Journal of Lipid Research|July 18, 2003
Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell lineLi Sun, Andrew C Nicholson, David P Hajjar, et al.
The Journal of Biological Chemistry|April 16, 2002
Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoproteinJihong Han, David P Hajjar, Xiaoye Zhou, et al.
The Journal of Biological Chemistry|November 22, 2007
Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanismXiaoye Zhou, Wei He, Zhiping Huang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 15, 2010
Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuliBrian D Lamon, Rita K Upmacis, Ruba S Deeb, et al.
Plos One|July 15, 2016
Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in MacrophagesHaijun Zhang, Brian D Lamon, George Moran, et al.
Circulation|February 19, 2004
Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36Jihong Han, Xiaoye Zhou, Toru Yokoyama, et al.
Circulation|November 24, 2004
Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104)Jihong Han, Michael Parsons, Xiaoye Zhou, et al.
The American Journal of Pathology|May 14, 2009
Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazoneHideaki Nakaya, Barbara D Summers, Andrew C Nicholson, et al.
Pageof 4